Impact of florbetaben PET imaging on diagnosis and management of patients with suspected Alzheimer's Disease eligible for CSF analysis in France - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Journal of Nuclear Medicine Année : 2017

Impact of florbetaben PET imaging on diagnosis and management of patients with suspected Alzheimer's Disease eligible for CSF analysis in France

(1) , (2) , (3, 4, 5) , (6) , (7) , (8) , (9) , (10) , (10) , (10) , (10) , (10) , (11, 12) , (12) , (13, 14) , (15, 16) , (17) , (18) , (10) , (19)
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
Santi Bullich
  • Fonction : Auteur
Nicola Raffa
  • Fonction : Auteur
Andrew Stephens
Eric Guedj
Fichier non déposé

Dates et versions

hal-03606881 , version 1 (12-03-2022)

Identifiants

  • HAL Id : hal-03606881 , version 1

Citer

Mathieu Ceccaldi, Therese Jonveaux, Antoine Verger, Pierre Krolak Salmon, Claire Houzard, et al.. Impact of florbetaben PET imaging on diagnosis and management of patients with suspected Alzheimer's Disease eligible for CSF analysis in France. Journal of Nuclear Medicine, 2017, 58 (S1), pp.561. ⟨hal-03606881⟩
16 Consultations
0 Téléchargements

Partager

Gmail Facebook Twitter LinkedIn More